Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2 results

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M; SMART Study Group. Pilcher J, et al. Respirology. 2014 Aug;19(6):842-51. doi: 10.1111/resp.12319. Epub 2014 Jun 2. Respirology. 2014. PMID: 24889937 Free article. Clinical Trial.
This study investigates outcomes for Māori in a randomized controlled trial (RCT) of combination budesonide/formoterol inhaler therapy in asthma. METHODS: This 24-week multicentre RCT recruited 303 adult asthma patients, 44 of whom …
This study investigates outcomes for Māori in a randomized controlled trial (RCT) of combination budesonide/formoterol
Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group. Patel M, et al. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):751-8. doi: 10.1016/j.jaip.2014.06.001. Epub 2014 Jul 25. J Allergy Clin Immunol Pract. 2014. PMID: 25439367 Clinical Trial.
OBJECTIVE: To investigate characteristics that predict subsequent adverse outcomes in asthma. METHODS: An independent 24-week, randomized controlled trial of 303 adult patients with asthma who are at risk, which compared the efficacy of SMART (single budesonide
OBJECTIVE: To investigate characteristics that predict subsequent adverse outcomes in asthma. METHODS: An independent 24-week, random …
Feedback